These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 18249216)

  • 21. Relation of -55CT polymorphism of UCP3 gene with weight loss and metabolic changes after a high monounsaturated fat diet in obese non diabetic patients.
    De Luis DA; Aller R; Izaola O; De La Fuente B; Conde R; Eiros Bouza JM
    Eur Rev Med Pharmacol Sci; 2013 Oct; 17(20):2810-5. PubMed ID: 24174365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia.
    Long S; Tian Y; Zhang R; Yang L; Xu Y; Jia L; Fu M
    Clin Chim Acta; 2006 Apr; 366(1-2):316-21. PubMed ID: 16364275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.
    Yin RX; Wu DF; Miao L; Htet Aung LH; Cao XL; Yan TT; Long XJ; Liu WY; Zhang L; Li M
    Biofactors; 2013; 39(3):315-25. PubMed ID: 23355348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of -55CT polymorphism of UCP3 gene with Trp64Arg polymorphism of beta3adrenoreceptor gene on insulin resistance in obese patients.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R; Castro MJ
    Eur Rev Med Pharmacol Sci; 2012 May; 16(5):610-6. PubMed ID: 22774401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relation of -55CT polymorphism of UCP3 gene with weight loss and metabolic changes after a high polyunsaturated fat diet in obese patients].
    de Luis DA; Aller R; Izaola O; GonzÁlez Sagrado M; Conde R; Ruiz Mambrilla M
    Nutr Hosp; 2012; 27(4):1190-5. PubMed ID: 23165529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association study of the -866G/A UCP2 gene promoter polymorphism with type 2 diabetes and obesity in a Tehran population: a case control study.
    Heidari J; Akrami SM; Heshmat R; Amiri P; Fakhrzadeh H; Pajouhi M
    Arch Iran Med; 2010 Sep; 13(5):384-90. PubMed ID: 20804304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic organization and mutational analysis of the human UCP2 gene, a prime candidate gene for human obesity.
    Lentes KU; Tu N; Chen H; Winnikes U; Reinert I; Marmann G; Pirke KM
    J Recept Signal Transduct Res; 1999; 19(1-4):229-44. PubMed ID: 10071761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uncoupling protein 3 genetic variants in human obesity: the c-55t promoter polymorphism is negatively correlated with body mass index in a UK Caucasian population.
    Halsall DJ; Luan J; Saker P; Huxtable S; Farooqi IS; Keogh J; Wareham NJ; O'Rahilly S
    Int J Obes Relat Metab Disord; 2001 Apr; 25(4):472-7. PubMed ID: 11319649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta2-adrenergic receptor and UCP3 variants modulate the relationship between age and type 2 diabetes mellitus.
    Pinelli M; Giacchetti M; Acquaviva F; Cocozza S; Donnarumma G; Lapice E; Riccardi G; Romano G; Vaccaro O; Monticelli A
    BMC Med Genet; 2006 Dec; 7():85. PubMed ID: 17150099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visceral obesity attenuates the effect of the hepatic lipase -514C>T polymorphism on plasma HDL-cholesterol levels in French-Canadian men.
    St-Pierre J; Miller-Felix I; Paradis ME; Bergeron J; Lamarche B; Després JP; Gaudet D; Vohl MC
    Mol Genet Metab; 2003 Jan; 78(1):31-6. PubMed ID: 12559845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uncoupling protein 2 gene polymorphisms are associated with obesity.
    Oktavianthi S; Trimarsanto H; Febinia CA; Suastika K; Saraswati MR; Dwipayana P; Arindrarto W; Sudoyo H; Malik SG
    Cardiovasc Diabetol; 2012 Apr; 11():41. PubMed ID: 22533685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of gene-obesity interaction effects on cholesterol levels: a genetic predisposition score on HDL-cholesterol is modified by obesity.
    Lamina C; Forer L; Schönherr S; Kollerits B; Ried JS; Gieger C; Peters A; Wichmann HE; Kronenberg F
    Atherosclerosis; 2012 Dec; 225(2):363-9. PubMed ID: 23058813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GG-genotype in the promotor region of uncoupling-protein-1 gene is associated with lower level of dehydroepiandrosterone in type 2 diabetes.
    Zietz B; Watzlawek E; Palitzsch KD; Schölmerich J; Schäffler A
    Exp Clin Endocrinol Diabetes; 2001; 109(2):102-6. PubMed ID: 11341297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
    Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The presence of at least three alleles of the ADRB3 Trp64Arg (C/T) and UCP1 -3826A/G polymorphisms is associated with protection to overweight/obesity and with higher high-density lipoprotein cholesterol levels in Caucasian-Brazilian patients with type 2 diabetes.
    Brondani LA; Duarte GC; Canani LH; Crispim D
    Metab Syndr Relat Disord; 2014 Feb; 12(1):16-24. PubMed ID: 24138564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of UCP2 and UCP3 variants on the manifestation of overweight in Korean children.
    Jun HS; Kim IK; Lee HJ; Lee HJ; Kang JH; Kim JR; Shin HD; Song J
    Obesity (Silver Spring); 2009 Feb; 17(2):355-62. PubMed ID: 19039313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATP-binding cassette transporter A1 (ABCA1) R219K (G1051A, rs2230806) polymorphism and serum high-density lipoprotein cholesterol levels in a large Japanese population: cross-sectional data from the Daiko Study.
    Mokuno J; Hishida A; Morita E; Sasakabe T; Hattori Y; Suma S; Okada R; Kawai S; Naito M; Wakai K
    Endocr J; 2015; 62(6):543-9. PubMed ID: 25877294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UCP1 -3826 A>G polymorphism affects weight, fat mass, and risk of type 2 diabetes mellitus in grade III obese patients.
    Nicoletti CF; de Oliveira AP; Brochado MJ; de Oliveira BP; Pinhel MA; Marchini JS; dos Santos JE; Salgado Junior W; Silva Junior WA; Nonino CB
    Nutrition; 2016 Jan; 32(1):83-7. PubMed ID: 26458326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis.
    Fares R; Petta S; Lombardi R; Grimaudo S; Dongiovanni P; Pipitone R; Rametta R; Fracanzani AL; Mozzi E; Craxì A; Fargion S; Sesti G; Valenti L
    Liver Int; 2015 May; 35(5):1574-80. PubMed ID: 25351290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel polymorphism in the proximal UCP3 promoter region: effect on skeletal muscle UCP3 mRNA expression and obesity in male non-diabetic Pima Indians.
    Schrauwen P; Xia J; Walder K; Snitker S; Ravussin E
    Int J Obes Relat Metab Disord; 1999 Dec; 23(12):1242-5. PubMed ID: 10643679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.